| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corporate Controller &CAO
1 company
German Christopher Paul is a Corporate Controller &CAO at RYTM. Recent filings cover 0 purchases and 9 sales.
Our model assigns German Christopher Paul a below-average insider score of 26/100, based on 6 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -46.5%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | RYTM Rhythm Pharmaceuticals, Inc. | Corporate Controller &CAO | Sale+OE | 4,643 | $92.21 | $428,131.03 | - | +28.2% | - | |
| Mar 4, 2026 | RYTM Rhythm Pharmaceuticals, Inc. | Corporate Controller &CAO | Sale+OE | 5,614 | $89.56 | $502,789.84 | -97.2% | -7.3% | - | |
| Aug 12, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Corporate Controller &CAO | Sale+OE10b5-1 | 1,500 | $95.00 | $142,500.00 | -61.9% | +1.2% | +21.9% | |
| Jul 9, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Corporate Controller &CAO | Sale+OE10b5-1 | 3,817 | $80.75 | $308,217.25 | -80.5% | +12.2% | +29.8% | |
| Jun 10, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Corporate Controller &CAO | Sale+OE10b5-1 | 2,069 | $67.19 | $139,016.11 | -52.3% | +48.1% | +27.2% | |
| Mar 21, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Corporate Controller &CAO | Sale+OE | 344 | $54.23 | $18,655.12 | -10.6% | +19.1% | +68.0% | |
| Feb 19, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Corporate Controller &CAO | Sale+OE | 635 | $57.22 | $36,334.70 | -23.5% | +10.1% | +77.9% | |
| Apr 2, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | Corporate Controller &CAO | Sale+OE | 368 | $41.76 | $15,367.68 | -31.6% | +6.5% | +29.7% |